FindTrial
Sign In

Contralateral Mueller’s Muscle-conjunctiva Resection: A Therapeutic Option In Thyroid Eye Disease Patients With Unilateral Eyelid Retraction

Contralateral Mueller’s Muscle-conjunctiva Resection: A Therapeutic Option In Thyroid Eye Disease Patients With Unilateral Eyelid Retraction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190305001
Enrollment
Unknown
Registered
2019-03-05
Start date
2018-06-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyelid position in thyroid eye disease patients who have unilateral eyelid retraction &#45

Interventions

Unilateral eyelid retraction in thyroid eye disease
Treatment

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) non-active TED patients with MRD1 of more than 4.5 mm in one eye (retracted eye) and not less than 2.5 mm in the other eye (normal eye). Non-active TED patient was defined as one with clinically and serologically euthyroid and had stable TED signs and symptoms for at least 6 months; (2) positive phenylephrine test on the normal eye.

Exclusion criteria

Exclusion criteria: 1. Negative phenylephrine test on the normal eye. 2. Refuse to have the operation (MMCR) on the normal eyelid.

Design outcomes

Primary

MeasureTime frame
pre- and post-operative MRD1 - iOS smartphone based-automate capture and measurement application (EyeAnalyze). (mm)—

Secondary

MeasureTime frame
pre- and post-operative MRD2, post phenylephrine test MRD1 and MRD2 - iOS smartphone based-automate capture and measurement application (EyeAnalyze). (mm)—

Countries

Thailand

Contacts

Public ContactPanida Potita

King Chulalongkorn Memorial Hospital

panidapotita@gmail.com+6686-831-9298

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026